William C. Cushman, MD, FACP, FAHA Veterans Affairs Medical Center, Memphis, TN For The ACCORD Study Group.
New Developments in Osteoporosis Douglas C. Bauer, MD University of California, San Francisco Research funding from NIH, Amgen, SKB, P and G, and Merck.
Using genetic markers in clinical practice David Thomas Advisor: Merck Clinical trial: Gilead and Merck.
Enabling and Supporting Provenance in e-Science Applications Luc Moreau University of Southampton [email protected].
Installed 3M Window Film Solutions for Commercial Buildings Jeff Franson, President Window Film Depot, Inc. [email protected].
IIB IIIA Inhibitors in the Management of High Risk Non-ST Elevation ACS Francis M. Fesmire, MD, FACEP Associate Professor University of Tennessee College.
1 Platform-Based Design Part 1, Introduction Wayne Wolf Princeton University Joerg Henkel NEC C&C Lab.
8 June 2004NCAC Society of Toxicology1 Detecting Liver Injury: Drug-Induced or Not ? John R. Senior, M.D., Hepatologist Associate Director for Science.
1 Real Options We will maintain our highly disciplined approach to capital spending. Our objective remains to maximize return on every dollar we invest.
Addex Pharmaceuticals Investor Presentation July 2010.
Literature Meeting March 25, 2008 Buchwald-Hartwig Coupling : Discovery, Optimization, and Applications David Marcoux Charette’s Laboratories.
HIV Resistance Testing: Overview of Indications and Cost Issues Paul E. Sax, MD Division of Infectious Diseases Brigham and Women’s Hospital Harvard Medical.